boosting Oncology exploration with Integrated KRAS Assay expert services and RAS Assays
from the quickly evolving subject of oncology investigate, exact and efficient mutation screening is critical for building targeted therapies. The KRAS companies Platform plays a pivotal position On this landscape by featuring detailed solutions for KRAS mutation profiling and Investigation. KRAS mutations, found in around ninety five% of RAS-conne